Investing

Milestone Pharma's Next Big Move After FDA Nod

courtesy of the U.S. Food and Drug Administration

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) shares more than doubled on Thursday after the company announced a key clinical and regulatory update. The firm also announced a private placement offering to capitalize on this gain and shore up its balance sheet.

The U.S. Food and Drug Administration (FDA) outlined an efficient path to registration for the company’s etripamil nasal spray. Recent interactions have management optimistic. Also, this path to registration would eliminate the need to start a new Phase 3 study.

The FDA agreed with Milestone’s plan to modify the ongoing NODE-301B study, which is now known as the RAPID study, to highlight the unique pharmacology of etripamil, including a primary endpoint of time to conversion within 30 minutes. This study, along with the recently completed NODE-301 study, which also now will use a 30-minute endpoint, will serve to fulfill the efficacy requirements for a New Drug Application (NDA) for etripamil in paroxysmal supraventricular tachycardia.

Note that the etripamil nasal spray is the company’s investigational short-acting calcium channel blocker for patients with paroxysmal supraventricular tachycardia — in simpler words, an abnormal heart rhythm.

At the same time, the company announced a private placement offering for $25 million with RTW Investments. Keep in mind that the company has a market cap of roughly $84 million, even after Thursday’s move.

The company expects that net proceeds from the private placement, along with current cash, cash equivalents and short-term investments, will be sufficient to fund planned operations through the second quarter of 2022.

Milestone Pharmaceuticals stock traded about 140% to $8.00 on Thursday, in a 52-week range of $1.69 to $24.01. The consensus price target is $4.00.

100 Million Americans Are Missing This Crucial Retirement Tool

The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.

Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.

A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.

Click here to learn how to get a quote in just a few minutes.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.